BioMarin Pharmaceutical Inc. buy Oppenheimer Holdings Inc.
Start price
24.02.26
/
50%
€53.20
Target price
24.02.27
€80.62
Performance (%)
-12.71%
Price
17.04.26
€46.44
Summary
This prediction is currently active. The price of BioMarin Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.71%. This prediction currently runs until 24.02.27. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.129% | -0.129% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $98.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.28
24.02.25
24.02.25
€93.59
24.02.26
24.02.26
-20.31%
25.02.26
25.02.26
